Skip to main content

J&J Broke Into A Sprint To Test Talcum Powder After Recall

J&J Broke Into A Sprint To Test Talcum Powder After Recall

J&J Broke Into A Sprint To Test Talcum Powder After Recall

Introduction

Johnson & Johnson (J&J) announced that they did not find any marks of contamination in their talcum powder during an independent testing done just 11 days after the U.S. Food and Drug Administration (FDA) warning.

The Pennsylvania laboratory where the tests were conducted discovered some amounts of asbestos in several baby powder samples, which was considered useless as the air conditioner at the lab was found to be contaminated. The follow-up tests conducted at the lab did not show any trace of asbestos.

Last month, J&J announced a voluntary recall of a single batch of its baby powder after receiving a warning from the FDA. The recall, applied to lot #22318RB, affected 33,000 bottles of talcum powder.

Nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits are consolidated under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Lawsuits are also pending in a coordinated California proceeding under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!